Genetic addiction risk score GARS trade a predictor of vulnerability to opioid dependence

Blum, Kenneth·2018·Frontiers in Bioscience
DOI 10.2741/e816

Cited by (105)

Items 101–105 of 105

  1. Index
    Steve Y. Sussman · 2020 · Cambridge University Press eBooks
  2. Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty Cases
    Kenneth Blum, Thomas McLaughlin, Kai‐Uwe Lewandrowski et al. · 2024 · Journal of Addiction Psychiatry
  3. Criterion validity of the genetic addiction risk severity (GARS) as a marker of reward deficiency in polydrug addiction: a multi-center study
    Kenneth Blum, Brett C. Haberstick, Andrew Smolen, David C. Han, Igor Elman, Catherine A. Dennen, Marlene Oscar‐Berman, David Eugene Smith, Thomas A. Simpatico, John Giordano et al. · 2025 · Journal of Translational Genetics and Genomics
  4. Understanding Intergenerational Transmission of Illicit Opioid Use Risk Based on Parent Drug Abuse History
    Thomas Walter Wojciechowski · 2025 · The Journal of Nervous and Mental Disease
  5. A Personalized Medicine Approach: Psychosocial and Genetic Risk Assessments Predictors of Bariatric Surgery Outcomes After 3 Years
    Panayotis K. Thanos, Shtakshe Chatrath, Colin Hanna et al. · 2026 · Biomedicines